The Cancer Discussion Group is Proudly Supported by:
Thursday, April 26, 2018 - Friday, April 27, 2018
The New York Academy of Sciences, 7 World Trade Center, 250 Greenwich St Fl 40, New York
Cancer Discussion Group
The New York Academy of Sciences
The recent FDA approval of a gene therapy for leukemia treatment marks a new frontier in medical innovation for the field of cancer immunotherapy. This 2-day scientific symposium will explore cutting-edge findings in basic science, translational research, and clinical studies to improve immunotherapeutic approaches. Plenary speakers active in the fields of cancer biology, immunology, and cancer immunotherapy will present on an array of topics, including: new mechanistic perspectives from basic and preclinical research, results from early phase clinical trials of combination therapies, the durability of treatment responses to CAR-T cell therapies, and managing the known toxicity of effective immunotherapies in clinical trials.
Abstract submissions are invited for a poster session. For complete submission instructions, please visit our online portal. The deadline for abstract submission is February 23, 2018.